Abrdn PLC Ascendis Pharma A/S Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Abrdn PLC holds 139,606 shares of ASND stock, worth $23.4 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
139,606
Previous 171,731
18.71%
Holding current value
$23.4 Million
Previous $26.8 Million
9.98%
% of portfolio
0.04%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding ASND
# of Institutions
272Shares Held
61.7MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.72 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$918 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$874 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$751 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$713 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.35B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...